Centrica PLC Transaction in Own Shares

RNS Number : 1900V

Centrica PLC

30 January 2025

 

Transactions in own shares   Centrica plc 30 January 2025   Centrica plc announces that it purchased on 29 January 2025 (through Goldman Sachs International) 1,000,000 Centrica plc ordinary shares of 6 14/81 pence each at a price of 137.9300 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the Company's buyback programme announced on 8 August 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Goldman Sachs International and pursuant to the Company's buyback programme update announced on 27 December 2024 and in accordance with the separate non-discretionary agreement with Goldman Sachs International.   Since 8 August 2024, Centrica has purchased 157,985,745 ordinary shares at a cost (excluding dealing and associated costs) of £196,468,172.42.   Following the above purchase, Centrica plc holds 501,588,518 ordinary shares in treasury, and has 5,066,518,696 ordinary shares in issue (excluding treasury shares).   In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Goldman Sachs International is set out below.   Transaction details: Centrica plc ordinary shares of 6 14/81 pence each   Issuer name: Centrica plc ISIN: GB00B033F229 Intermediary name: Goldman Sachs International Intermediary Code: GSILGB2XXXX Currency: GBP   Aggregated information Date of purchase: 29 January 2025 Number of ordinary shares purchased: 1,000,000 Highest price paid: 139.2500p Lowest price paid: 135.5500p Volume weighted average price paid per share: 137.9300p   Disaggregated information   The table attached contains detailed information of the individual trades made by Goldman Sachs International, as part of the buyback programme.   Click on, or paste the following link into your web browser, to view the associated PDF document. http://www.rns-pdf.londonstockexchange.com/rns/1900V_1-2025-1-29.pdf   END   Enquiries: Investors and Analysts T: 01753 494900 E: [e-mail]     Centrica plc is listed on the London Stock Exchange (CNA) Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD Registered in England & Wales number: 3033654 Legal Entity Identifier number: E26EDV109X6EEPBKVH76 ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSZZGZMRLFGKZM